Copyright
©The Author(s) 2022.
World J Clin Pediatr. May 9, 2022; 11(3): 215-220
Published online May 9, 2022. doi: 10.5409/wjcp.v11.i3.215
Published online May 9, 2022. doi: 10.5409/wjcp.v11.i3.215
Disease | Comment |
Type 1 ROP (ETROP)[9] | Treat as soon as you possible, preferably on the day that screening was done. Laser recommended |
AROP[10] | Treat as soon as possible. Laser if disease is amenable. Intravitreal injections can be used, but caution to be exercised since follow-up may be a critical issue with travel restrictions for the family |
Less than Type 1 ROP. Stage 2 with pre plus, stage 3 with no or early plus, high risk for APROP (but not yet full fledged), borderline Zone 1 disease/poor pupil dilatation, unclear media with pre-plus | Given the difficulty to closely follow-up consider treatment a ‘little earlier’ than classical Type 1 ROP |
Stage 4A and 4B ROP[10] | Surgery must be performed as soon as treating ROP specialist feels it is required with adequate precautions taken while providing anesthesia |
Stage 5 ROP[10] | Surgery is not urgent. Case-to-case based decision must be considered |
- Citation: Vinekar A, Azad R, Dogra MR, Jalali S, Bhende P, Chandra P, Venkatapathy N, Kulkarni S. Preferred practice guidelines for retinopathy of prematurity screening during the COVID-19 pandemic. World J Clin Pediatr 2022; 11(3): 215-220
- URL: https://www.wjgnet.com/2219-2808/full/v11/i3/215.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v11.i3.215